Literature DB >> 1849397

Intravenous methylphenidate abuse. Prototype for prescription drug abuse.

T V Parran1, D R Jasinski.   

Abstract

Data are presented from a case series of 22 patients who abused methylphenidate hydrochloride (Ritalin-SR). The abuse pattern and symptoms of toxicity were similar to that seen with cocaine hydrochloride and amphetamine sulfate addiction; yet, the morbidity and mortality seen in this case series were greater than usual for a group of patients involved in intravenous drug abuse. We describe the characteristics of the methylphenidate abuse syndrome in terms of the pharmacology of methylphenidate, the constituents of the Ritalin-SR preparation, and the disease of chemical dependence. We propose solutions to the problem of methylphenidate abuse.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849397

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  26 in total

Review 1.  [New developments in the pharmacotherapy of cocaine dependence].

Authors:  G Wiesbeck; K Dürsteler-MacFarland
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

2.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

3.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

Review 4.  Safety issues in the use of methylphenidate. An American perspective.

Authors:  M D Rappley
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

5.  Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates.

Authors:  Joel A Beverley; Cassandra Piekarski; Vincent Van Waes; Heinz Steiner
Journal:  Basal Ganglia       Date:  2014-12-01

6.  Assessing methylphenidate preference in ADHD patients using a choice procedure.

Authors:  Emily MacDonald Fredericks; Scott H Kollins
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

7.  Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.

Authors:  P K Thanos; C Bermeo; M Rubinstein; K L Suchland; G J Wang; D K Grandy; N D Volkow
Journal:  J Psychopharmacol       Date:  2009-03-12       Impact factor: 4.153

8.  Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Authors:  S J Wanchoo; M J Lee; A C Swann; N Dafny
Journal:  Brain Res       Date:  2009-11-22       Impact factor: 3.252

9.  Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbens.

Authors:  Yong Kim; Merilee A Teylan; Matthew Baron; Adam Sands; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

10.  Examining the Frequency of Stimulant Misuse among Patients with Primary Disorders of Hypersomnolence: A Retrospective Cohort Study.

Authors:  William G Mantyh; R Robert Auger; Timothy I Morgenthaler; Michael H Silber; Wendy R Moore
Journal:  J Clin Sleep Med       Date:  2016-05-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.